Literature DB >> 15703903

Screening children for sickle cell vasculopathy: guidelines for transcranial Doppler evaluation.

Dorothy Bulas1.   

Abstract

Cerebral infarction is a major cause of morbidity and mortality in children with sickle cell disease. Prevention of primary stroke might be feasible with a way to identify children at greatest risk. Transcranial Doppler (TCD) has been shown to be a noninvasive, reliable, inexpensive method of identifying children at highest risk for cerebral infarction. The pros and cons of imaging and non-imaging TCD techniques are discussed. The protocol for the stroke prevention trial in sickle cell anemia (STOP), including data acquisition and interpretation, is reviewed. Providing TCD to sickle cell patients can be a valuable service that results in a significant decrease in first stroke rates.

Entities:  

Mesh:

Year:  2005        PMID: 15703903     DOI: 10.1007/s00247-005-1417-7

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  21 in total

1.  Implementation of the STOP protocol for Stroke Prevention in Sickle Cell Anemia by using duplex power Doppler imaging.

Authors:  A J Malouf; J E Hamrick-Turner; M C Doherty; G S Dhillon; R V Iyer; M G Smith
Journal:  Radiology       Date:  2001-05       Impact factor: 11.105

2.  Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.

Authors:  E P Vichinsky; N L Luban; E Wright; N Olivieri; C Driscoll; C H Pegelow; R J Adams
Journal:  Transfusion       Date:  2001-09       Impact factor: 3.157

3.  The natural history of stroke in sickle cell disease.

Authors:  D Powars; B Wilson; C Imbus; C Pegelow; J Allen
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

4.  Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia.

Authors:  A M Jones; J J Seibert; F T Nichols; D L Kinder; K Cox; J Luden; E M Carl; D Brambilla; S Saccente; R J Adams
Journal:  Pediatr Radiol       Date:  2001-07

5.  Screening for stroke in sickle cell anemia: comparison of transcranial Doppler imaging and nonimaging US techniques.

Authors:  Ariane S Neish; David E Blews; Catherine A Simms; Robert K Merritt; Alice J Spinks
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

6.  Stroke prevention in sickle cell disease (STOP) study guidelines for transcranial Doppler testing.

Authors:  F T Nichols; A M Jones; R J Adams
Journal:  J Neuroimaging       Date:  2001-10       Impact factor: 2.486

7.  Cerebrovascular disease in symptomatic and asymptomatic patients with sickle cell anemia: screening with duplex transcranial Doppler US--correlation with MR imaging and MR angiography.

Authors:  J J Seibert; S F Miller; R S Kirby; D L Becton; C A James; C M Glasier; A R Wilson; D L Kinder; D H Berry
Journal:  Radiology       Date:  1993-11       Impact factor: 11.105

8.  Cerebral blood flow in sickle cell cerebrovascular disease.

Authors:  P R Huttenlocher; J W Moohr; L Johns; F D Brown
Journal:  Pediatrics       Date:  1984-05       Impact factor: 7.124

9.  The use of transcranial ultrasonography to predict stroke in sickle cell disease.

Authors:  R Adams; V McKie; F Nichols; E Carl; D L Zhang; K McKie; R Figueroa; M Litaker; W Thompson; D Hess
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

10.  Cerebral infarction in sickle cell disease: transcranial Doppler US versus neurologic examination.

Authors:  M J Siegel; G D Luker; T A Glauser; M R DeBaun
Journal:  Radiology       Date:  1995-10       Impact factor: 11.105

View more
  9 in total

1.  Problems with implementing a standardised transcranial Doppler screening programme: impact of instrumentation variation on STOP classification.

Authors:  Soundrie T Padayachee; Nicholas Thomas; Andrew J Arnold; Baba Inusa
Journal:  Pediatr Radiol       Date:  2011-10-15

2.  Hemodynamic responses to visual stimulation in children with sickle cell anemia.

Authors:  Ping Zou; Kathleen J Helton; Matthew Smeltzer; Chin-Shang Li; Heather M Conklin; Amar Gajjar; Winfred C Wang; Russell E Ware; Robert J Ogg
Journal:  Brain Imaging Behav       Date:  2011-12       Impact factor: 3.978

Review 3.  Prospects for primary stroke prevention in children with sickle cell anaemia.

Authors:  Lori C Jordan; James F Casella; Michael R DeBaun
Journal:  Br J Haematol       Date:  2012-01-09       Impact factor: 6.998

Review 4.  Transcranial Doppler in children.

Authors:  Suzanne Verlhac
Journal:  Pediatr Radiol       Date:  2011-04-27

Review 5.  Transcranial Doppler in children with sickle cell disease: Five years of screening experience.

Authors:  Amanda Crow
Journal:  Australas J Ultrasound Med       Date:  2020-02-20

6.  Ischemic stroke in infants and children: practical management in emergency.

Authors:  Sara Ciccone; Michela Cappella; Caterina Borgna-Pignatti
Journal:  Stroke Res Treat       Date:  2011-07-03

7.  Practice Recommendations for Transcranial Doppler Ultrasonography in Critically Ill Children in the Pediatric Intensive Care Unit: A Multidisciplinary Expert Consensus Statement.

Authors:  Nicole Fortier O'Brien; Karin Reuter-Rice; Mark S Wainwright; Summer L Kaplan; Brian Appavu; Jennifer C Erklauer; Suman Ghosh; Matthew Kirschen; Brandi Kozak; Karen Lidsky; Marlina Elizabeth Lovett; Amy R Mehollin-Ray; Darryl K Miles; Craig A Press; Dennis W Simon; Robert C Tasker; Kerri Lynn LaRovere
Journal:  J Pediatr Intensive Care       Date:  2020-09-04

8.  Transcranial Doppler Ultrasonography in Beta-thalassemia Major Patients Without and With Thrombocytosis.

Authors:  Abdolhamid Shariat; Masoume Nazeri; Amin Abolhasani Foroughi; Mehran Karimi
Journal:  Iran Red Crescent Med J       Date:  2013-03-05       Impact factor: 0.611

9.  Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy.

Authors:  Aikaterini Kanavaki; Konstantinos Spengos; Maria Moraki; Polyxeni Delaporta; Catherine Kariyannis; Ioannis Papassotiriou; Antonis Kattamis
Journal:  Int J Mol Sci       Date:  2017-12-15       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.